Formic Acid

Formic Acid

SCHEMBL27693231

O=C(NC1CCC1)c1cc(Cl)c2ccccc2c1OCc1ccc(OC(F)(F)F)cc1.O=CO

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 3/20 0.45
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
GCGR P47871 3/20 0.43
SGMS2 Q8NHU3 1/20 0.42
CHRM1 P11229 1/20 0.42
CNR2 P34972 6/20 0.41
CNR1 P21554 5/20 0.41
MAOB P27338 1/20 0.41
SLC6A5 Q9Y345 1/20 0.41
EPHX1 P07099 1/20 0.39
EPHX2 P34913 1/20 0.39
LIPE Q05469 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL485783 0.97 MRGPRX4 (0.47) MRGPRX4MEN1ALDH1A1KMT2AGCGR
Formic Acid SCHEMBL27693269 0.90 MRGPRX4 (0.54) MRGPRX4MEN1ALDH1A1KMT2ASGMS2
Formic Acid SCHEMBL27693247 0.89 CNR1 (0.52) MEN1ALDH1A1KMT2ASGMS2CNR2
Formic Acid SCHEMBL27712967 0.89 KMT2A (0.55) MRGPRX4MEN1ALDH1A1KMT2ASGMS2
Formic Acid SCHEMBL27693432 0.88 CXCR2 (0.46) MEN1ALDH1A1KMT2ASGMS2CHRM1
Formic Acid SCHEMBL27693212 0.88 CXCR2 (0.50) MRGPRX4MEN1ALDH1A1KMT2ASGMS2
SCHEMBL486088 0.87 MRGPRX4 (0.56) MRGPRX4MEN1ALDH1A1KMT2ASGMS2
SCHEMBL485710 0.85 MRGPRX4 (0.56) MRGPRX4MEN1ALDH1A1KMT2ASGMS2
SCHEMBL485455 0.84 CXCR2 (0.49) MEN1ALDH1A1KMT2ASGMS2CHRM1
SCHEMBL486231 0.83 CXCR2 (0.52) MRGPRX4MEN1ALDH1A1KMT2ASGMS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN claimed
CN-101094830-A Fused bicyclic carboxamide derivatives for use as CXCR2 inhibitors in the treatment of inflammation SANOFI AVENTIS DEUTSCHLAND (DE) 2007-12-26 CN disclosed